WuXi Biologics (Cayman) Inc.
WXIBF | OTC
$6.01
$0 (0.00%)
At close: Sep 21, 2026, 4:00 PM ET
$6.01
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:00 PM ET
Market Data
Market Cap $24.9B
Enterprise Value $171.89B
Beta 0.60
Average Volume N/A
Shares Outstanding (Diluted) 4.19B
Shares Change YoY -3.77%
Institutional Ownership N/A
Exchange N/A
ISIN N/A
Price Performance
Price Change 1M -6.8%
Price Change 3M 50.3%
Price Change 6M 30.6%
Price Change YTD 42.4%
Price Change 1Y 20.2%
Price Change 3Y 15.4%
Price Change 5Y -60.1%
1M CAGR (ann.) 30.6%
1Y CAGR (ann.) 27.6%
5Y CAGR (ann.) -14.6%
All-Time CAGR 44.2%
Valuation
PE Ratio 44.25
Forward PE 21.80
PEG Ratio 1.87
Forward PEG 1.53
PS Ratio 8.96
Forward PS 5.20
PB Ratio 3.97
P/FCF Ratio 102.13
P/Adj. FCF Ratio 234.87
P/OCF Ratio 38.71
EV/Sales 8.57
EV/EBIT 29.15
EV/EBITDA 23.21
EV/FCF 97.71
Earnings Yield 2.4%
FCF Yield 1.1%
Adj. FCF Yield 0.5%
Financial Health
Net Cash ¥8.86B
Total Debt ¥5.11B
Cash & Short-Term Investments ¥12.54B
Total Assets ¥60.44B
Current Ratio 3.04
Quick Ratio 2.82
Debt / Equity Ratio 0.06
Debt / EBITDA 0.69
Debt / FCF 2.90
OCF / Debt 1.12
Interest Coverage 74.60
Altman Z-Score 10.88
Piotroski F-Score 8
Margins & Profitability
Gross Profit Margin 47.5%
Operating Profit Margin 29.3%
EBITDA Margin 37.4%
Net Profit Margin 21.2%
FCF Margin 8.8%
Adj. FCF Margin 3.8%
SBC / Revenue 1.9%
SBC Impact (per share) -56.5%
Returns
Return on Assets 7.7%
Return on Equity 10.5%
Return on Invested Capital 10.6%
Return on Capital Employed 13.4%
Return on Tangible Assets 8.0%
Historical Growth (CAGR)
Revenue CAGR 3Y 86.6%
Revenue CAGR 5Y 116.9%
Revenue CAGR 10Y 49.6%
EPS CAGR 3Y 67.1%
EPS CAGR 5Y 150.7%
EPS CAGR 10Y 51.4%
FCF CAGR 3Y 487.9%
FCF CAGR 5Y 96.7%
FCF CAGR 10Y 6.7%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y 37.3%
Revenue Growth Next 3Y 28.4%
Earnings Date Mar 22, 2027
EPS Estimate (next Q) $0.02
EPS Growth Est (next Q) 19.8%
Revenue Est (next Q) $306.66M
Revenue Growth Est (next Q) 21.4%
Fair Value Estimates
Graham Number $2.39
Graham Upside -60.2%
Lynch Fair Value $3.40
Lynch Upside -43.4%
Price Target N/A
Price Target Upside N/A
Cash Flow
Operating Cash Flow ¥5.72B
Free Cash Flow ¥1.76B
Adj. Free Cash Flow ¥764.94M
FCF Per Share $0.68
OCF Per Share $1.12
OCF/S Ratio 19.5%
Income Statement
Revenue ¥20.05B
Gross Profit ¥8.55B
Operating Income ¥5.88B
EBITDA ¥7.41B
Net Income ¥4.2B
EPS (Diluted) $0.98
Revenue / Employee N/A
Profit / Employee N/A
Employees N/A
Add to Watchlist
Select watchlists to add or remove WXIBF